Nalaganje...
Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy
Tumour infiltration by regulatory T (Treg) cells contributes to suppression of the anti‐tumour immune response, which limits the efficacy of immune‐mediated cancer therapies. The phosphoinositide 3‐kinase (PI3K) pathway has key roles in mediating the function of many immune cell subsets, including T...
Shranjeno v:
| izdano v: | Immunology |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587315/ https://ncbi.nlm.nih.gov/pubmed/31107985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13082 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|